Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




System for 3-D Live Cell Microscopy to Be Available Soon

By LabMedica International staff writers
Posted on 18 Mar 2015
An exciting breakthrough in live cell microscopy will soon be available to biotech and other life scientists in the form of a new microscope that is to be marketed by a Swiss startup company.

Nanolive SA (Lausanne, Switzerland) has begun taking pre-orders for its revolutionary 3D Cell Explorer microscope system. More...
This microscope is described as delivering true live cell tomography through the use of completely harmless laser light for three-dimensional (3-D) cell scans. This technology allows the researcher to look inside living cells without the use of labeling or markers or any other invasive methods that may potentially modify, damage, or even kill the cell.

The manufacturer says that it requires only a few moments to get up and running with the 3D Cell Explorer. The researcher simply switches on the microscope, positions the sample, and commences acquisition with the dedicated "STEVE" software. Within seconds, a full 3-D image of the cell is loaded to the screen. STEVE’s intuitive interface is used to control the microscope, explore data using interactive digital staining, and even perform quantitative analyses on measurements. Results can easily be shared online or even sent to a 3-D printer.

Related Links:

Nanolive SA



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.